cancer related pain. Neoplasm related pain (acute) (chronic)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Any type of cancer Suffering from moderate to severe pain caused by cancer based on VAS score (5-10) Informed consent to participate in the study Absence of depressive disorders, bipolar disorders, or psychotic disorders based on DSM-V diagnostic criteria during examination by a psychiatrist and a psychiatric assistant No history of epilepsy and other neurological disorders Absence of pregnancy No addiction to drugs and opium Not having implants in the skull or pacemakers or any other prosthetics No prior exposure to transcranial stimulation treatments
Exclusion criteria
Exclusion criteria: The final stage of cancer Lack of informed consent Aggravation of cancer symptoms and the need for hospitalization during the study Intensification of pain in such a way that it is necessary to prescribe strong narcotics (morphine, methadone, oxycodone, pethidine)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score of cancer patients according to VAS (Visual Analog Scale). Timepoint: before the intervention and one week, two weeks, three weeks and four weeks after the intervention. Method of measurement: The pain score of the patients is measured by the Visual Analog Scale ruler. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences